Oct 19, 2020 / 01:00PM GMT
Tim Metcalfe - IFC Advisory - IR
Well, good afternoon, everybody. It seems most people have joined now. Welcome to the Midatech Pharma question-and-answer session. Today, I've got Stephen Stamp, CEO and CFO; and Steve Damment, Executive Vice President of R&D, with me.
The session is specifically to answer questions on the announcement this morning. Steve and Stephen will give some introductory remarks. We will then move to the question-and-answer session. (Operator Instructions) So on that basis, I'll hand over to Stephen to start the session. Stephen?
Stephen A. Stamp - Midatech Pharma plc - CEO, CFO & Director
Thank you, Tim, and good afternoon, everybody, in the U.K. and good morning, colleagues, in the U.S. Very pleased to have made this morning's announcement, very exciting news for a very important program of Midatech, MTX110 in DIPG. I don't intend to steal any of his thunder, so I'm going to pass you straight on to Steve Damment, our EVP of R&D. Steve?
Steve Damment - Midatech Pharma plc - EVP of
Midatech Pharma plc - Special Call Transcript
Oct 19, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers